Clinical and morphological criteria in the diagnosis of amyloidosis of the liver and gallbladder

DOI: https://doi.org/10.29296/25877305-2019-12-18
Download full text PDF
Issue: 
12
Year: 
2019

Z. Gioeva(1), L. Mikhaleva(2) 1-North Ossetian State Medical Academy, Ministry of Health of Russia, Vladikavkaz 2-Research Institute of Human Morphology, Moscow

The clinical and morphological features of amyloidosis of the liver and gallbladder were investigated when examining the biopsy specimens with histologically confirmed amyloidosis. The material was fixed in formalin and embedded in paraffin. Sections were stained with hematoxylin and eosin, as well as with Congo red. Amyloid deposits were immunohistochemically classified using a broad panel of antibodies to different types of amyloidosis.
Keywords: 
amyloidosis
hepatic amyloidosis
gallbladder amyloidosis
immunohistochemistry

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Takayasu V., Laborda L., Bernardelli R. et al. Amyloidosis: an unusual cause of portal hypertension // Autops Case Rep. – 2016; 6 (2): 9–18. DOI: 10.4322/acr.2016.035.
  2. Wang Y., Zhao C., Yin H. Primary hepatic amyloidosis: a mini literature review and five cases report // Ann. Hepatol. – 2012; 11 (5): 721–7.
  3. Ebert E., Nagar M. Gastrointestinal manifestations of amyloidosis // Am. J. Gastroenterol. – 2008; 103 (3): 776–87. DOI: 10.1111/j.1572-0241.2007.01669.x.
  4. Girnius S., Seldin D., Skinner M. et al. Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease // Haematologica. – 2009; 94 (7): 1029–32. DOI: 10.3324/haematol.2008.001925.
  5. Park M., Mueller P., Kyle R. et al. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients // Medicine (Baltimore). – 2003; 82 (5): 291–8. DOI: 10.1097/01.md.0000091183.93122.c7.
  6. Hasan S., Ahmed N., Ahmed Z. et al. Response of Bortezomib Chemotherapy in Hepatic Amyloidosis // J. Investig. Med. High Impact Case Rep. – 2018; 6: 2324709618760079. DOI: 10.1177/2324709618760079.
  7. Misiakos E., Bagias G., Tiniakos D. et al. Primary Amyloidosis Manifesting as Cholestatic Jaundice after Laparoscopic Cholecystectomy // Case Rep Surg. – 2015; 2015: 353818. DOI: 10.1155/2015/353818.
  8. Mihaleva L.M., Gioeva Z.V., Reken K. Gistologicheskoe i immunogistohimicheskoe issledovanija v diagnostike amiloidoza pecheni // Arhiv patologii. – 2015; 77 (4): 11–6 [Mikhaleva L.M., Gioeva Z.V., Reken K. Histological and immunohistochemical examinations in the diagnosis of hepatic amyloidosis // Archive of Pathology = Arkhiv Patologii. – 2015; 77 (4): 11–6 (in Russ.)] DOI: 10.17116/patol201577411-16.
  9. Katoh N., Matsushima A., Kurozumi M. et al. Marked and rapid regression of hepatic amyloid deposition in a patient with systemic light chain (AL) amyloidosis after highdose melphalan therapy with stem cell transplantation // Intern. Med. – 2014; 53 (17): 1991–5. DOI: 10.2169/internalmedicine.53.2065.
  10. Yim B., Kertowidjojo E., Zhang Y. et al. Poor Outcomes in Hepatic Amyloidosis: A Report of 2 Cases // Case Rep. Oncol. Med. – 2016; 2016: 7625940. DOI: 10.1155/2016/7625940.
  11. Makhlouf H., Goodman Z. Globular hepatic amyloid: an early stage in the pathway of amyloid formation: a study of 20 new cases // Am. J. Surg. Pathol. – 2007; 31: 1615–21. DOI: 10.1097/PAS.0b013e318054e6b6.
  12. Nair A., Yadav M., Unni M. et al. Hepatic Amyloidosis: Something That Can camouflage and Deceive our Perception! // Indian J. Med. Paediatr. Oncol. – 2017; 38 (2): 236–9. DOI: 10.4103/ijmpo.ijmpo_46_16.
  13. Premkumar M., Rangegowda D., Vyas T. et al. Primary Hepatic Amyloidosis Presenting as Acute-on-Chronic Liver Failure // ACG Case Rep. J. – 2017; 4: e22. DOI: 10.14309/crj.2017.22.
  14. Tirotta D., Durante V. Uncommon localization of amyloidosis in gallbladder: description of a case and brief literature review // Ann. Hepatol. – 2011; 10 (2): 227–32.
  15. Zhang L., Tang H., Chen L. et al. Analysis of clinical and imaging features of cardiac amyloidosis: a multicenter study // Nan Fang Yi Ke Da Xue Xue Bao. – 2014; 34 (3): 295–302.
  16. Shin Y. Hepatic amyloidosis // Korean J. Hepatol. – 2011; 17 (1): 80–3. DOI: 10.3350/kjhep.2011.17.1.80.
  17. Al Knawy B., Shiffman M. Percutaneous liver biopsy in clinical practice // Liver Int. – 2007; 27: 1166–73. DOI: 10.1111/j.1478-3231.2007.01592.x.
  18. Merlini G., Seldin D., Gertz M. Amyloidosis: Pathogenesis and New Therapeutic Options // J. Clin. Oncol. – 2011; 29 (14): 1924–33. DOI: 10.1200/JCO.2010.32.2271.
  19. Matsuda S., Nishikata M., Takai K. et al. An Unusual Case of Acute Cholecystitis with Amyloidosis: A Case Report and Literature Review // Intern. Med. – 2018; 58 (6): 803–7. DOI: 10.2169/internalmedicine.1805-18.